---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-047951"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2023-09-13T23:59:59+00:00"
generated_at: "2026-06-10T18:56:58.395345+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals appoints James Robinson to board effective Oct 1, 2023

## Summary
- Robinson will serve as chair of the Compensation Committee and member of Audit Committee.
- Annual cash retainers of $42k for board service, $15.75k as comp chair, $10.5k for audit committee.
- Granted option to purchase 150,437 shares vesting over two years at market price on grant date.
- Board determined Robinson qualifies as independent under Nasdaq rules; no family relationships or arrangements.

## SEC filing metadata
- accession: 0000950170-23-047951
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2023-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017023047951/0000950170-23-047951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017023047951/eldn-20230911.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-047951
- JSON: https://secwatch.observer/filing/0000950170-23-047951.json
- Plain text: https://secwatch.observer/filing/0000950170-23-047951.txt

## Key facts
- Executive change
  James Robinson was appointed as director at Eledon Pharmaceuticals, Inc..
  - Action: appointed
  - Role: director
  source text: On September 11, 2023, James Robinson was appointed to the board of directors (the “Board”) of Eledon Pharmaceuticals, Inc., (“Eledon”), effective October 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404281/000095017023047951/0000950170-23-047951-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.